This is an observational study, meaning no new treatments are being tested. Instead, researchers are creating a national registry of 4,000 patients who receive Fecal Microbiota Transplantation (FMT) or other gut-related microbiota products. The goal is to understand the short-term and long-term safety and effectiveness of these treatments over 10 years. You can join if you are receiving FMT or a similar product within 90 days of consenting, have internet or phone access, and can provide informed consent. Donors can also join if they provide a stool sample and can give informed consent. The study is looking to see how often side effects happen and if the disease comes back after FMT.

Study design

This is an observational study enrolling 4,000 participants across 75 sites in North America. It is not testing a specific treatment but rather collecting information on existing practices.

What's involved

If you are a recipient, you will provide information at regular intervals up to 10 years after FMT, including through your healthcare provider and direct communication with researchers. If you are a donor, you will provide a stool sample.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 10 years after Fecal Microbiota Transplantation (FMT).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.